Istituto Luso Farmaco D'italia S.p.a.

A. Menarini Industrie Farmaceutiche Riunite S.r.l.

Menarini Ricerche S.p.a.

Sandro Giuliani

Carlo Alberto Maggi

Vittorio Pestellini

Alberto Meli

Danilo Giannotti

Maria Altamura

Laura Quartara

Paolo Rovero

Enzo Perrotta

Riccardo Patacchini

Paolo Santicioli

Disclosed are pharmaceutical compositions containing, as the active ingredients, a mixture of a hyaluronic acid polymer with a bradykinin B2 receptor antagonist. Said compositions have proved especially effective in the treatment of degenerative joint diseases such as osteoarthritis using intra-articular injections.

Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and uses thereof

Disclosed are pharmaceutical compositions containing, as active ingredients, a mixture of a corticosteroid and a kinin B2 receptor antagonist. Said compositions have proved particularly effective, especially in the treatment of inflammatory disorders such as asthma, ophthalmic or dermatological disorders and, above all, as regards the joints, arthritis.

Pharmaceutical compositions based on kinin B2 receptor antagonists and corticosteroids, and their use

Basic monocyclic compounds having general formula (I) useful as NK-2 antagonists are described, processes for their preparation and pharmaceutical compositions containing them are also described.

Basic monocyclic compounds having Nk2 antagonist action, processes for their preparation, and formulations containing them

A synthetic peptide corresponding to the following formula:

Synthetic peptide antagonists of neurokinin A, salts thereof and

Growing community of inventors

Bagno a Ripoli, Italy

Sandro Giuliani